Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 961.50 |
| Low | 961.50 |
| Bid | -- |
| Offer | -- |
| Previous close | 961.50 |
| Average volume | -- |
|---|---|
| Shares outstanding | 44.88m |
| Free float | 44.06m |
| P/E (TTM) | 844.32 |
| Market cap | 1.64bn USD |
| EPS (TTM) | 0.0432 USD |
Data delayed at least 20 minutes, as of Dec 02 2024 11:30 GMT.
More ▼
Press releases
- Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results
- Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
- Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management
- Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show
- Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference
- Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies
More ▼
